Arsenic trioxide and all‐trans retinoic acid treatment for childhood acute promyelocytic leukaemia-Reference-Cited by-同舟云学术

Arsenic trioxide and all‐trans retinoic acid treatment for childhood acute promyelocytic leukaemia

Published:2018-07-20 Issue:2 Volume:185 Page:360-363
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Strocchio Luisa¹^ORCID,Gurnari Carmelo¹²,Santoro Nicola³,Putti Maria C.⁴,Micalizzi Concetta⁵,Zecca Marco⁶^ORCID,Cuccurullo Rosanna⁷,Girardi Katia¹,Diverio Daniela⁸,Testi Anna M.⁸,Lo‐Coco Francesco²,Locatelli Franco¹⁹^ORCID

Affiliation:

1. Department of Paediatric Haematology/Oncology IRCCS Bambino Gesù Children's Hospital RomeItaly

2. University of Tor Vergata RomeItaly

3. Paediatric Haematology/Oncology Policlinico di Bari BariItaly

4. Department of Women's and Children's Health University of Padova PaduaItaly

5. Clinical Experimental Haematology Unit IRCCS Istituto Giannina Gaslini GenovaItaly

6. Paediatric Haematology/Oncology Fondazione IRCCS Policlinico San Matteo PaviaItaly

7. Department of Paediatric Haemato‐Oncology Santobono‐Pausilipon Hospital NaplesItaly

8. Department of Cellular Biotechnologies and Haematology La Sapienza University RomeItaly

9. Department of Paediatric Sciences University of Pavia Pavia Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Ministero della Salute

Regione Lazio

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.15507

Reference9 articles.

1. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

2. Long-term prognosis of childhood acute promyelocytic leukaemia with arsenic trioxide administration in induction and consolidation chemotherapy phases: a single-centre experience

3. First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acid

4. Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative study

5. Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy-free treatment for acute promyelocytic leukemia: the pediatric view of a revolutionary tale;Frontiers in Oncology;2023-04-14

2. Childhood acute promyelocytic leukemia in a pediatric cancer referral center in Baghdad, Iraq. Improved results with ATRA extended consolidation;Leukemia & Lymphoma;2022-08-01

3. PRMT5-mediated RNF4 methylation promotes therapeutic resistance of APL cells to As2O3 by stabilizing oncoprotein PML-RARα;Cellular and Molecular Life Sciences;2022-05-27

4. HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA?;Mediterranean Journal of Hematology and Infectious Diseases;2022-04-28

5. Long non-coding RNAs and microRNAs as crucial regulators in cardio-oncology;Cell & Bioscience;2022-03-04